Recent Updates — ETST
Ernesto L. Flores resigned as Chief Financial Officer and board member effective October 25, 2026, citing no disagreements with the company. CEO Giorgio R. Saumat will serve as interim principal financial officer until a successor is named. The filing notes that Mr. Flores remains available as a consultant to assist with the independent auditor's review of the Form 10-Q for the quarter ended September 30, 2026. Earth Science Tech operates in the environmental technology sector.
Earth Science Tech, Inc. acquired Zoolzy LLC, a Florida-based wholesale distributor of active pharmaceutical ingredients and finished FDA-approved prescription products, on August 17, 2026. The transaction was structured as a related-party sale with Mario G. Tabraue, the Company’s Chief Operations Officer and Board member, serving as the seller. Terms were undisclosed due to immateriality but were approved by independent directors. The acquisition aims to expand margin through internalized API procurement and facilitate strategic entry into the veterinary market for custom compounding therapeutics. Earth Science Tech operates as a diversified holding company focused on a vertically integrated healthcare platform combining compounding pharmacy operations, telemedicine, and clinical support.
Earth Science Tech, Inc. entered into an agreement to acquire Meduvo LLC, a compounding pharmacy based in La Verne, California, from Chief Operations Officer and Board Member Mario G. Tabraue. The transaction was reviewed by independent directors for fairness, though specific financial terms were deemed immaterial. This acquisition expands the company's operational network to 34 U.S. jurisdictions and establishes a West Coast hub. Meduvo currently operates a 2,000-square-foot facility dispensing non-sterile medications, with management targeting sterile compounding certification by the end of 2028. Earth Science Tech, Inc. is a diversified holding company focused on building a vertically integrated healthcare platform combining compounding pharmacy operations, telemedicine, and clinical support.
Earth Science Tech, Inc. reported fiscal first quarter 2027 results for the period ended June 30, 2026. Revenue increased 3% to $9.0 million from $8.8 million, while net income grew 57% year-over-year to $715,697 with diluted EPS tripling to $0.003. Net cash provided by operating activities rose 108% to $707,131. The company repurchased and retired 3.7 million shares of common stock, up from 505,000 in the prior-year quarter. Total assets reached $10.4 million on June 30, 2026. Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, building a vertically integrated healthcare platform combining compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment.